WS Audiology halts IPO plans for subsidiary

Hearing aid firm WS Audiology has withdrawn its filings with the US Securities and Exchange Commission for listing This is due to unfavorable market conditions, the company says, while maintaining that going public is still an attractive opportunity.

Photo: Eric Thayer/Reuters/Ritzau Scanpix

According to a Wednesday registration with the US Securities and Exchange Commission (SEC), WS Audiology, the third-biggest hearing group in the world, has withdrawn its submission concerning an initial public offering of its subsidiary

As the short message reads, ”the registration statement is being withdrawn because a determination has been made not to proceed with the initial public offering of the company’s common shares contemplated in the registration statement at this time.”

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs